Drug Profile
Research programme: NF-kappa B/IKK inhibitors - Nereus Pharmaceuticals
Alternative Names: NPI-1342; NPI-1387; NPI-1390Latest Information Update: 16 Jan 2014
Price :
$50
*
At a glance
- Originator Nereus Pharmaceuticals
- Class Diterpenes; Small molecules
- Mechanism of Action I-kappa B kinase inhibitors; NF-kappa B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Inflammation